speb/financial-data huggingface dataset:
Financial ratios for HPK — quarterly report dated 2025-09-30
Total revenue: 188862000
Gross profit: 44898000
Operating income: 32829000
Net income: -18335000
Capital expenditures: 117633000
Operating cash flow: 120239000
Depreciation & amortization: 100636000
Net tangible assets: 1626502000
Owner earnings: -35332000
Return on net tangible assets (%): -2.1722690780583114
Capex to operating income (%): 358.32038746230467
Buffett classification: The Gruesome
Stock price: 7.03
P/E ratio: 20.108146303875408
Shares outstanding: 126358104
Book value: 1626502000
P/B ratio: 0.5461397963974223
Market cap (USD): 888297471.12
Debt to equity: 0.7337906747117433
Current ratio: 1.6460348542500312
Quick ratio: 1.581159581644214
Interest coverage ratio: 0.9112585355021373
COGS to revenue (%): 76.22708644407027
SG&A to revenue (%): 5.033304741027841
Free cash flow (dilution-adjusted): 2429000
Buyback yield (%): 0
Retained earnings: 463286000
Inventory turnover: 14.533010296789824
Receivables turnover: 3.4618007185277513
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0756309899940009
FCF margin (%): 1.2861242600417235
Revenue growth (%): -5.75748502994012
Rule of 40 score: -4.471360769898396
Financial ratios for HPK — quarterly report dated 2025-12-31
Total revenue: 216649000
Gross profit: 1102000
Operating income: -16324000
Net income: -23178000
Capital expenditures: 88533000
Operating cash flow: 93093000
Depreciation & amortization: 110589000
Net tangible assets: 1594569000
Owner earnings: -1122000
Return on net tangible assets (%): -0.07036384126368944
Buffett classification: The Gruesome
Stock price: 4.74
P/E ratio: 28.52354571673493
Shares outstanding: 126358104
Book value: 1594569000
P/B ratio: 0.3756108471693605
Market cap (USD): 598937412.96
Debt to equity: 0.7486624912437154
Current ratio: 1.1287306302550204
Quick ratio: 1.0955154263081093
Interest coverage ratio: -0.4544543429844098
COGS to revenue (%): 99.49134314028683
SG&A to revenue (%): 1.89338515294324
Free cash flow (dilution-adjusted): -1867000
Buyback yield (%): 0
Retained earnings: 432549000
Inventory turnover: 28.183446652719667
Receivables turnover: 3.9003528606920392
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5471503201989102
FCF margin (%): -0.8617625744868428
Revenue growth (%): 14.712859124651862
Rule of 40 score: 13.85109655016502
Financial ratios for HPK — annual report dated 2025-12-31
Total revenue: 863359000
Gross profit: 196466000
Operating income: 152817000
Net income: 18963000
Capital expenditures: 515337000
Operating cash flow: 511597000
Depreciation & amortization: 421776000
Net tangible assets: 1594569000
Owner earnings: -74598000
Return on net tangible assets (%): -4.678254750970325
Capex to operating income (%): 337.224916076091
Buffett classification: The Gruesome
Stock price: 4.74
P/E ratio: 31.584528448030376
Shares outstanding: 126358104
Book value: 1594569000
P/B ratio: 0.3756108471693605
Market cap (USD): 598937412.96
Debt to equity: 0.7486624912437154
Current ratio: 1.1287306302550204
Quick ratio: 1.0955154263081093
Effective tax rate (%): 27.53362885967594
Interest coverage ratio: 1.0818519698417755
COGS to revenue (%): 77.24399699313959
SG&A to revenue (%): 2.9986367200666235
Free cash flow (dilution-adjusted): -11179000
Buyback yield (%): 0
Retained earnings: 432549000
Inventory turnover: 87.19835251046025
Receivables turnover: 15.543135419292119
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.122143499254891
FCF margin (%): -1.294826370026837
Revenue growth (%): -22.71944860921521
Rule of 40 score: -24.014274979242046
Financial ratios for IBU.DE — annual report dated 2021-12-31
Total revenue: 50101136.36363637
Gross profit: 25417560.693181816
Operating income: 1057911.625
Net income: -266603.1477272727
Capital expenditures: 4880681.818181818
Operating cash flow: -1282954.5454545454
Depreciation & amortization: 5228071.875
Net tangible assets: 61731343.715909086
Owner earnings: 80786.90909090918
Capex to operating income (%): 461.35061784407736
Buffett classification: The Gruesome
Stock price: 50.68181818181818
Shares outstanding: 4750000
Book value: 66025170.48863637
P/B ratio: 3.646164554850639
Market cap (USD): 240738636.36363634
Debt to equity: 0.1399333211559641
Current ratio: 5.045580512019835
Quick ratio: 3.26772863433189
Effective tax rate (%): 148.6882178303011
Interest coverage ratio: 1.9568692101463265
COGS to revenue (%): 49.267496631812925
Free cash flow (dilution-adjusted): -6447727.2727272725
Buyback yield (%): 0
Retained earnings: 14547897.761363635
Inventory turnover: 1.5573937089282923
Receivables turnover: 6.3185280619347095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.343716126492882
FCF margin (%): -12.86942321213908
Rule of 40 score: -12.86942321213908
Financial ratios for IBU.DE — annual report dated 2022-12-31
Total revenue: 57387733.94680851
Gross profit: 28453315.340425536
Operating income: 2058821.8510638298
Net income: 1366889.0212765958
Capital expenditures: 10161702.127659574
Operating cash flow: -3478723.4042553194
Depreciation & amortization: 5053224.531914894
Net tangible assets: 59242954
Owner earnings: -3741588.5744680846
Return on net tangible assets (%): -6.315668483492712
Capex to operating income (%): 493.5687914138294
Buffett classification: The Gruesome
Stock price: 36.15957446808511
P/E ratio: 125.65612573505946
Shares outstanding: 4750000
Book value: 63177686.925531924
P/B ratio: 2.718649369449959
Market cap (USD): 171757978.7234043
Debt to equity: 0.10722556271963193
Current ratio: 4.7233024730164095
Quick ratio: 1.7911134388104415
Effective tax rate (%): 22.433641687327274
Interest coverage ratio: 6.883908008893873
COGS to revenue (%): 50.4191690740075
Free cash flow (dilution-adjusted): -14146808.510638298
Buyback yield (%): 0
Retained earnings: 14986197.563829789
Inventory turnover: 1.3046870672828244
Receivables turnover: 6.665234436687442
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.794763123357674
FCF margin (%): -24.65127569551828
Revenue growth (%): 14.543777071812663
Rule of 40 score: -10.107498623705617
Financial ratios for IBU.DE — annual report dated 2023-12-31
Total revenue: 53591035.52222222
Gross profit: 26409813.22222222
Operating income: -1979193.6888888888
Net income: -2762429.322222222
Capital expenditures: 7356666.666666666
Operating cash flow: 2680000
Depreciation & amortization: 5277190.544444445
Net tangible assets: 58957529.28888889
Owner earnings: -4841905.444444444
Return on net tangible assets (%): -8.21253112680376
Buffett classification: The Gruesome
Stock price: 19.91111111111111
Shares outstanding: 4750000
Book value: 63012043.7
P/B ratio: 1.5009476319806745
Market cap (USD): 94577777.77777778
Debt to equity: 0.14945996391762448
Current ratio: 2.6699129915810476
Quick ratio: 0.7643892257086295
Interest coverage ratio: -4.040011134288771
COGS to revenue (%): 50.71971839157493
Free cash flow (dilution-adjusted): -5464444.444444444
Buyback yield (%): 0
Retained earnings: 12678710.366666667
Inventory turnover: 1.1140951806844703
Receivables turnover: 6.063457263599966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.7689155937475602
FCF margin (%): -10.196564390286023
Revenue growth (%): -6.615870959646827
Rule of 40 score: -16.812435349932848
Financial ratios for IBU.DE — annual report dated 2024-12-31
Total revenue: 52720413.22916667
Gross profit: 24432825.354166668
Operating income: -3899736.7395833335
Net income: -5526369.479166667
Capital expenditures: 5650000
Operating cash flow: 9705208.333333334
Depreciation & amortization: 4964583.333333334
Net tangible assets: 48880476.59375
Owner earnings: -6211786.145833333
Return on net tangible assets (%): -12.708112888219242
Buffett classification: The Gruesome
Stock price: 6.90625
Shares outstanding: 4750000
Book value: 53547421.500000015
P/B ratio: 0.6126287051935823
Market cap (USD): 32804687.5
Debt to equity: 0.1321661817008935
Current ratio: 1.8365147612376584
Quick ratio: 0.6817271580026998
Interest coverage ratio: -7.224425327542417
COGS to revenue (%): 53.65585385690864
Free cash flow (dilution-adjusted): 2426041.666666667
Buyback yield (%): 0
Retained earnings: 6359921.5
Inventory turnover: 1.9886405304077106
Receivables turnover: 7.732315443168484
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.545206661885311
FCF margin (%): 4.601712160564972
Revenue growth (%): -1.6245670279958193
Rule of 40 score: 2.9771451325691527
Financial ratios for IBU.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 48880476.59375
Buffett classification: The Gruesome
Stock price: 6.90625
Shares outstanding: 4750000
Book value: 53547421.500000015
P/B ratio: 0.6126287051935823
Market cap (USD): 32804687.5
Debt to equity: 0.1321661817008935
Current ratio: 1.8365147612376584
Quick ratio: 0.6817271580026998
Buyback yield (%): 0
Retained earnings: 6359921.5
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBU.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 54209564.705882356
Buffett classification: The Gruesome
Stock price: 7.588235294117648
Shares outstanding: 4750000
Book value: 59743094.11764706
P/B ratio: 0.6033185622438666
Market cap (USD): 36044117.64705883
Debt to equity: 0.165307021456381
Current ratio: 8.040442039214554
Quick ratio: 3.156930419619552
Buyback yield (%): 0
Retained earnings: 6801917.647058824
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IES.L — annual report dated 2021-12-31
Total revenue: 4304054.054054054
Gross profit: -4644594.594594595
Operating income: -29240540.540540542
Net income: -28881081.08108108
Capital expenditures: 990540.5405405406
Operating cash flow: -31032432.43243243
Depreciation & amortization: 982432.4324324324
Net tangible assets: 36679729.72972973
Owner earnings: -28889189.18918919
Return on net tangible assets (%): -78.76063810190473
Buffett classification: The Gruesome
Stock price: 0.012297297297297298
Shares outstanding: 569388085
Book value: 69243243.24324325
P/B ratio: 0.10112083476775957
Market cap (USD): 7001934.5587837845
Debt to equity: 0.015027322404371584
Current ratio: 2.6993525131833658
Quick ratio: 2.3123957012215475
Interest coverage ratio: -480.84444444444443
COGS to revenue (%): 207.91208791208794
R&D to revenue (%): 56.26373626373626
SG&A to revenue (%): 115.13343799058084
Free cash flow (dilution-adjusted): -34516216.21621622
Buyback yield (%): 0
Retained earnings: -193995945.94594595
Inventory turnover: 1.142314990512334
Receivables turnover: 1.892453951277481
Capitalized R&D asset: 2421621.621621622
ROCI (R&D-adjusted, %): -38.24615231110779
FCF margin (%): -801.9466248037677
Rule of 40 score: -801.9466248037677
Financial ratios for IES.L — annual report dated 2022-12-31
Total revenue: 3546987.9518072293
Gross profit: 20481.927710843374
Operating income: -22809638.55421687
Net income: -22333734.93975904
Capital expenditures: 853012.0481927712
Operating cash flow: -26351807.228915665
Depreciation & amortization: 1626506.0240963856
Net tangible assets: 12457831.325301206
Owner earnings: -21560240.963855423
Return on net tangible assets (%): -173.06576402321085
Buffett classification: The Gruesome
Stock price: 0.005060240963855421
Shares outstanding: 569388085
Book value: 41433734.93975904
P/B ratio: 0.06953852739168362
Market cap (USD): 2881240.9120481927
Debt to equity: 0.04969467868566444
Current ratio: 1.4657565158524202
Quick ratio: 0.9113731242243033
Interest coverage ratio: -291.26153846153846
COGS to revenue (%): 99.42255434782608
R&D to revenue (%): 74.18478260869564
SG&A to revenue (%): 203.0570652173913
Free cash flow (dilution-adjusted): -28025301.204819277
Buyback yield (%): 0
Retained earnings: -195293975.90361446
Inventory turnover: 0.2978528543807876
Receivables turnover: 1.6948762233736328
Capitalized R&D asset: 4253811.787691306
ROCI (R&D-adjusted, %): -46.66016678073852
Rosenberg metric: 1.926426688898451
FCF margin (%): -790.1154891304346
Revenue growth (%): -17.589604887367365
Rule of 40 score: -807.705094017802
Financial ratios for IES.L — annual report dated 2023-12-31
Total revenue: 27855696.202531643
Gross profit: -4246835.443037975
Operating income: -28391139.24050633
Net income: -29340506.329113923
Capital expenditures: 1245569.6202531646
Operating cash flow: -24505063.291139238
Depreciation & amortization: 1770886.075949367
Net tangible assets: 12418987.341772152
Owner earnings: -28815189.87341772
Return on net tangible assets (%): -232.02527774946486
Buffett classification: The Gruesome
Stock price: 0.004430379746835442
Shares outstanding: 569388085
Book value: 42801265.822784804
P/B ratio: 0.05893763633809481
Market cap (USD): 2522605.4398734174
Debt to equity: 0.04601780380327093
Current ratio: 2.0006943480072215
Quick ratio: 1.5440910984585476
Interest coverage ratio: -23.65928270042194
COGS to revenue (%): 115.24584204307916
R&D to revenue (%): 8.488594019812778
SG&A to revenue (%): 24.356993547214394
Free cash flow (dilution-adjusted): -26741772.15189873
Buyback yield (%): 0
Retained earnings: -234522784.81012657
Inventory turnover: 7.713199513381995
Receivables turnover: 8.81650641025641
Capitalized R&D asset: 4926680.048967681
ROCI (R&D-adjusted, %): -58.23499403292123
Rosenberg metric: -1.6217369128761534
FCF margin (%): -96.00109061165136
Revenue growth (%): 685.3338263621353
Rule of 40 score: 589.3327357504838
Financial ratios for IES.L — annual report dated 2024-12-31
Total revenue: 6268750
Gross profit: -4391250
Operating income: -29808750
Net income: -28496250
Capital expenditures: 1626250
Operating cash flow: -31172500
Depreciation & amortization: 1728750
Net tangible assets: 52137500
Owner earnings: -28393750
Return on net tangible assets (%): -54.45936226324623
Buffett classification: The Gruesome
Stock price: 0.002
Shares outstanding: 569388085
Book value: 82086250
P/B ratio: 0.013872922322557067
Market cap (USD): 1138776.17
Debt to equity: 0.02581126558954758
Current ratio: 6.704452872594466
Quick ratio: 5.8963337547408345
Interest coverage ratio: -224.97169811320754
COGS to revenue (%): 170.04985044865404
R&D to revenue (%): 48.275174476570285
SG&A to revenue (%): 97.3678963110668
Free cash flow (dilution-adjusted): -33576250
Buyback yield (%): 0
Retained earnings: -260087500
Inventory turnover: 1.4823570311142014
Receivables turnover: 6.064087061668682
Capitalized R&D asset: 5478840.513954553
ROCI (R&D-adjusted, %): -32.359128636950885
Rosenberg metric: -0.06107467880085655
FCF margin (%): -535.6131605184447
Revenue growth (%): -77.49562619285649
Rule of 40 score: -613.1087867113013
Financial ratios for IES.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 52137500
Buffett classification: The Gruesome
Stock price: 0.002
Shares outstanding: 569388085
Book value: 82086250
P/B ratio: 0.013872922322557067
Market cap (USD): 1138776.17
Debt to equity: 0.02581126558954758
Current ratio: 6.704452872594466
Quick ratio: 5.8963337547408345
Buyback yield (%): 0
Retained earnings: -260087500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IES.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 43542465.75342466
Buffett classification: The Gruesome
Stock price: 0.003287671232876712
Shares outstanding: 569388085
Book value: 76347945.20547946
P/B ratio: 0.024518810851544833
Market cap (USD): 1871960.82739726
Debt to equity: 0.043976746689632897
Current ratio: 4.22834131475838
Quick ratio: 3.114279494993469
Buyback yield (%): 0
Retained earnings: -298660273.9726027
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JUBLCPL.NS — annual report dated 2025-03-31
Total revenue: 181921907.8793547
Gross profit: 70400981.99672668
Operating income: 49667991.5828852
Net income: 10258358.66261398
Capital expenditures: 4113864.8585457094
Operating cash flow: 15120411.503390227
Depreciation & amortization: 1882160.3927986906
Net tangible assets: 37821019.406125784
Owner earnings: 8026654.196866961
Return on net tangible assets (%): 21.222733609255656
Capex to operating income (%): 8.28272842818811
Buffett classification: The Great
Stock price: 14.648733807912242
P/E ratio: 21.637461097182353
Shares outstanding: 15152493
Book value: 38053542.20247837
P/B ratio: 5.8329612339951185
Market cap (USD): 221964836.4832536
Debt to equity: 0.23685601056803168
Current ratio: 1.4574885969186218
Quick ratio: 0.9330156711508235
Effective tax rate (%): 25.106022052586933
Interest coverage ratio: 31.564635958395243
COGS to revenue (%): 61.301537117005964
SG&A to revenue (%): 13.167155048324078
Free cash flow (dilution-adjusted): 10674538.227729717
Buyback yield (%): 0
Retained earnings: 18711947.626841243
Inventory turnover: 5.006823072482025
Receivables turnover: 5.413295300379171
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 114.29539896858128
FCF margin (%): 5.867648570841045
Revenue growth (%): 21.27904190161101
Rule of 40 score: 27.146690472452054
Financial ratios for JUBLCPL.NS — quarterly report dated 2025-03-31
Total revenue: 46394669.160626605
Gross profit: 17526303.48375029
Operating income: 11727846.621463642
Net income: 1871638.9992985737
Capital expenditures: 0
Depreciation & amortization: 500350.71311667055
Net tangible assets: 37821019.406125784
Owner earnings: 2371989.7124152444
Return on net tangible assets (%): 6.271617607512342
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.648733807912242
P/E ratio: 29.6484573903459
Shares outstanding: 15152493
Book value: 38053542.20247837
P/B ratio: 5.8329612339951185
Market cap (USD): 221964836.4832536
Debt to equity: 0.23685601056803168
Current ratio: 1.4574885969186218
Quick ratio: 0.9330156711508235
Effective tax rate (%): 24.587847385774847
Interest coverage ratio: 45.80821917808219
COGS to revenue (%): 62.22345411480119
Buyback yield (%): 0
Retained earnings: 18711947.626841243
Inventory turnover: 1.2960688605468955
Receivables turnover: 1.3805266636518594
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.98798292267588
Rule of 40 score: 0
Financial ratios for JUBLCPL.NS — quarterly report dated 2025-06-30
Total revenue: 51622981.5118184
Gross profit: 23269365.78516265
Operating income: 17388251.81371402
Net income: 5163819.33068102
Capital expenditures: 0
Depreciation & amortization: 469225.36859349406
Owner earnings: 5633044.699274515
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.065527732272407
P/E ratio: 14.719858937457513
Shares outstanding: 15152493
Market cap (USD): 304042768.5045635
Effective tax rate (%): 24.188283800034355
Interest coverage ratio: 84.43181818181819
COGS to revenue (%): 54.92440555794818
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.269209255680751
Rule of 40 score: 11.269209255680751
Financial ratios for JUBLCPL.NS — quarterly report dated 2025-09-30
Total revenue: 57702367.53100338
Gross profit: 24253664.03607666
Operating income: 18297632.468996618
Net income: 4766629.08680947
Capital expenditures: 0
Depreciation & amortization: 485907.55355129647
Net tangible assets: 46395715.896279596
Owner earnings: 5252536.640360767
Return on net tangible assets (%): 11.321167351104416
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 26.10597519729425
P/E ratio: 20.746873693708608
Shares outstanding: 15152493
Book value: 46767756.48252537
P/B ratio: 8.458190774726996
Market cap (USD): 395570606.4351747
Debt to equity: 0.09982402429911046
Current ratio: 1.5205831542577843
Quick ratio: 1.0037500526692789
Effective tax rate (%): 27.602739726027398
Interest coverage ratio: 125.81395348837209
COGS to revenue (%): 57.96764487515142
Buyback yield (%): 0
Inventory turnover: 1.209399967389532
Receivables turnover: 1.3277816691311903
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 35.52977232924693
Revenue growth (%): 11.776510850682232
Rule of 40 score: 11.776510850682232
Financial ratios for JUBLCPL.NS — quarterly report dated 2025-12-31
Total revenue: 50081318.92614459
Gross profit: 20516876.462069735
Operating income: 14468085.10638298
Net income: 2397237.384426869
Capital expenditures: 0
Depreciation & amortization: 517990.4199621255
Owner earnings: 2915227.8043889944
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.979391778990756
P/E ratio: 26.656201219018726
Shares outstanding: 15152493
Market cap (USD): 378500059.07541496
Effective tax rate (%): 25.76750603656433
Interest coverage ratio: 65.92893401015229
COGS to revenue (%): 59.03287512789714
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -13.207514580340243
Rule of 40 score: -13.207514580340243
Financial ratios for MHA.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 23039189.18918919
Buffett classification: The Gruesome
Stock price: 0.01945945945945946
Shares outstanding: 284067414
Book value: 63831081.08108109
P/B ratio: 0.08660041836773577
Market cap (USD): 5527798.326486486
Debt to equity: 0.4429554355880173
Current ratio: 1.2229006262766842
Quick ratio: 1.2229006262766842
Buyback yield (%): 0
Retained earnings: 44750000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MIDWESTLTD.NS — quarterly report dated 2025-12-31
Total revenue: 14354127.213991312
Gross profit: 9057368.831458172
Operating income: 2441795.7001225357
Net income: 2039545.5051799044
Capital expenditures: 0
Depreciation & amortization: 960565.890609335
Owner earnings: 3000111.3957892396
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.166759496491032
P/E ratio: 84.95589602053633
Shares outstanding: 36160816
Market cap (USD): 693085663.4688649
Effective tax rate (%): 22.823236588292815
Interest coverage ratio: 4.677763551002988
COGS to revenue (%): 36.90059523347587
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -46.65826584219644
Rule of 40 score: -46.65826584219644
Financial ratios for MKTW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 110.79
Shares outstanding: 2638780
Market cap (USD): 292350436.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MKTW — annual report dated 2022-12-31
Total revenue: 512403000
Gross profit: 449706000
Operating income: 87283000
Net income: 101170000
Capital expenditures: 35000
Operating cash flow: 48374000
Depreciation & amortization: 3091000
Net tangible assets: -68551000
Owner earnings: 104226000
Return on net tangible assets (%): -152.0415457104929
Capex to operating income (%): 0.04009944662763654
Buffett classification: The Great
Stock price: 24.68
P/E ratio: 0.6437193871701097
Shares outstanding: 2638780
Book value: -298383000
Market cap (USD): 65125090.4
Debt to equity: -0.024515471725936128
Current ratio: 0.724178093207369
Quick ratio: 0.724178093207369
Effective tax rate (%): 1.4513929475939995
COGS to revenue (%): 12.235876839128576
R&D to revenue (%): 1.7207159208669738
SG&A to revenue (%): 68.40611784084012
Free cash flow (dilution-adjusted): 39158000
Buyback yield (%): 20.04450192671057
Retained earnings: -128125000
Receivables turnover: 92.29160662824208
Capitalized R&D asset: 8817000
ROCI (R&D-adjusted, %): 141.54119631109558
FCF margin (%): 7.642031760157532
Rule of 40 score: 7.642031760157532
Financial ratios for MKTW — annual report dated 2023-12-31
Total revenue: 448182000
Gross profit: 391380000
Operating income: 54388000
Net income: 54295000
Capital expenditures: 65000
Operating cash flow: 62428000
Depreciation & amortization: 3821000
Net tangible assets: -48374000
Owner earnings: 58051000
Return on net tangible assets (%): -120.00454789763096
Capex to operating income (%): 0.11951165698315805
Buffett classification: The Great
Stock price: 43.39
P/E ratio: 2.1087883635693894
Shares outstanding: 2638780
Book value: -288943000
Market cap (USD): 114496664.2
Debt to equity: -0.02011469390156536
Current ratio: 0.7163573535744183
Quick ratio: 0.7163573535744183
Effective tax rate (%): 3.2140183250739778
COGS to revenue (%): 12.673869097821866
R&D to revenue (%): 1.970404880160292
SG&A to revenue (%): 72.36792196027507
Free cash flow (dilution-adjusted): 37317000
Buyback yield (%): 0
Retained earnings: -126343000
Receivables turnover: 46.156745623069
Capitalized R&D asset: 14738390
ROCI (R&D-adjusted, %): 153.30410547412296
Rosenberg metric: -6.615175229669956
FCF margin (%): 8.326304938618687
Revenue growth (%): -12.533298985368937
Rule of 40 score: -4.20699404675025
Financial ratios for MKTW — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 59000
Buffett classification: The Gruesome
Stock price: 10.89
Shares outstanding: 2638780
Market cap (USD): 28736314.200000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MKTW — annual report dated 2024-12-31
Total revenue: 408701000
Gross profit: 358038000
Operating income: 93433000
Net income: 93108000
Capital expenditures: 133000
Operating cash flow: -22150000
Depreciation & amortization: 2753000
Net tangible assets: -47252000
Owner earnings: 95728000
Return on net tangible assets (%): -202.59036654533142
Capex to operating income (%): 0.1423479926792461
Buffett classification: The Great
Stock price: 9.44
P/E ratio: 0.26753966576448857
Shares outstanding: 2638780
Book value: -217924000
Market cap (USD): 24910083.2
Debt to equity: -0.020039096198674767
Current ratio: 0.6488386214105638
Quick ratio: 0.6488386214105638
Effective tax rate (%): 3.3758470750614875
COGS to revenue (%): 12.396103753110465
R&D to revenue (%): 2.4242661505599448
SG&A to revenue (%): 61.645065708182756
Free cash flow (dilution-adjusted): -35033000
Buyback yield (%): 43.36798040080412
Retained earnings: -119284000
Receivables turnover: 168.6756087494841
Capitalized R&D asset: 18734380
ROCI (R&D-adjusted, %): 521.8872761765822
Rosenberg metric: -3.7755633563582833
FCF margin (%): -8.571792092507726
Revenue growth (%): -8.809144499332861
Rule of 40 score: -17.380936591840587
Financial ratios for MKTW — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 56000
Buffett classification: The Gruesome
Stock price: 9.44
Shares outstanding: 2638780
Market cap (USD): 24910083.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MKTW — quarterly report dated 2025-03-31
Total revenue: 83507000
Gross profit: 71572000
Operating income: 17160000
Net income: 16841000
Capital expenditures: 45000
Operating cash flow: 1733000
Depreciation & amortization: 531000
Net tangible assets: -50240000
Owner earnings: 17327000
Return on net tangible assets (%): -34.48845541401273
Capex to operating income (%): 0.26223776223776224
Buffett classification: The Great
Stock price: 8.76
P/E ratio: 0.3431463808562437
Shares outstanding: 2638780
Book value: -217731000
Market cap (USD): 23115712.8
Debt to equity: -0.008097147397476703
Current ratio: 0.6160956034038164
Quick ratio: 0.6160956034038164
Effective tax rate (%): 5.805693830751161
COGS to revenue (%): 14.292215023890211
R&D to revenue (%): 2.809345324344067
SG&A to revenue (%): 61.55891122899877
Free cash flow (dilution-adjusted): -1630000
Buyback yield (%): 0
Retained earnings: -118394000
Receivables turnover: 8.051195526417278
Capitalized R&D asset: 2346000
FCF margin (%): -1.951932173350737
Rule of 40 score: -1.951932173350737
Financial ratios for MKTW — quarterly report dated 2025-06-30
Total revenue: 79950000
Gross profit: 69000000
Operating income: 14811000
Net income: 15310000
Capital expenditures: 118000
Operating cash flow: 17842000
Depreciation & amortization: 500000
Net tangible assets: -49924000
Owner earnings: 15692000
Return on net tangible assets (%): -31.43177629997596
Capex to operating income (%): 0.796705151576531
Buffett classification: The Great
Stock price: 17.87
P/E ratio: 1.4666728437684675
Shares outstanding: 2638780
Book value: -227018000
Market cap (USD): 47154998.6
Debt to equity: -0.006651454950708754
Current ratio: 0.5429381385192824
Quick ratio: 0.5429381385192824
Effective tax rate (%): 3.8497770520630534
COGS to revenue (%): 13.696060037523452
R&D to revenue (%): 2.6779237023139464
SG&A to revenue (%): 64.2526579111945
Free cash flow (dilution-adjusted): 14946000
Buyback yield (%): 3.9253526772451224
Retained earnings: -117097000
Receivables turnover: 16.487935656836463
Capitalized R&D asset: 3712820
Rosenberg metric: -1.0963341858482523
FCF margin (%): 18.694183864915573
Revenue growth (%): -4.25952315374759
Rule of 40 score: 14.434660711167982
Financial ratios for MKTW — quarterly report dated 2025-09-30
Total revenue: 81271000
Gross profit: 70672000
Operating income: 17820000
Net income: 17915000
Capital expenditures: 15000
Operating cash flow: 2169000
Depreciation & amortization: 651000
Net tangible assets: -48525000
Owner earnings: 18551000
Return on net tangible assets (%): -38.229778464708914
Capex to operating income (%): 0.08417508417508417
Buffett classification: The Great
Stock price: 15.24
P/E ratio: 0.8032398673750649
Shares outstanding: 2638780
Book value: -225951000
Market cap (USD): 40215007.2
Debt to equity: -0.02716960756978283
Current ratio: 0.5105544696149953
Quick ratio: 0.5105544696149953
Effective tax rate (%): 5.626086498445978
COGS to revenue (%): 13.041552337242065
R&D to revenue (%): 2.6343960330253102
SG&A to revenue (%): 61.432737384799005
Free cash flow (dilution-adjusted): -1058000
Buyback yield (%): 2.610965589980051
Retained earnings: -115592000
Receivables turnover: 17.583513630463003
Capitalized R&D asset: 4349650
Rosenberg metric: 0.780943484353106
FCF margin (%): -1.3018173764319376
Revenue growth (%): 1.6522826766729206
Rule of 40 score: 0.350465300240983
Financial ratios for MKTW — annual report dated 2025-12-31
Total revenue: 328122000
Gross profit: 283787000
Operating income: 62976000
Net income: 64041000
Capital expenditures: 391000
Operating cash flow: 45958000
Depreciation & amortization: 2186000
Net tangible assets: -45538000
Owner earnings: 65836000
Return on net tangible assets (%): -144.57376257191797
Capex to operating income (%): 0.6208714430894309
Buffett classification: The Great
Stock price: 14.18
P/E ratio: 0.5842803891257163
Shares outstanding: 2638780
Book value: -213625000
Market cap (USD): 37417900.4
Debt to equity: -0.028475131655939144
Current ratio: 0.5623345459513928
Quick ratio: 0.5623345459513928
Effective tax rate (%): 3.8408985119896695
COGS to revenue (%): 13.51174258355124
R&D to revenue (%): 2.686195988077605
SG&A to revenue (%): 63.942984621573686
Free cash flow (dilution-adjusted): 33285000
Buyback yield (%): 9.030437207535034
Retained earnings: -113664000
Receivables turnover: 50.01859756097561
Capitalized R&D asset: 18366590
ROCI (R&D-adjusted, %): 2463.248071745115
Rosenberg metric: -7.494045215987081
FCF margin (%): 10.144092745990822
Revenue growth (%): -19.715880313481005
Rule of 40 score: -9.571787567490183
Financial ratios for MKTW — quarterly report dated 2025-12-31
Total revenue: 83394000
Gross profit: 72543000
Operating income: 13185000
Net income: 13975000
Capital expenditures: 213000
Operating cash flow: 24214000
Depreciation & amortization: 504000
Net tangible assets: -45538000
Owner earnings: 14266000
Return on net tangible assets (%): -31.32768237515921
Capex to operating income (%): 1.61547212741752
Buffett classification: The Great
Stock price: 14.18
P/E ratio: 0.5842803891257163
Shares outstanding: 2638780
Book value: -213625000
Market cap (USD): 37417900.4
Debt to equity: -0.028475131655939144
Current ratio: 0.5623345459513928
Quick ratio: 0.5623345459513928
Effective tax rate (%): -1.1654842912986825
COGS to revenue (%): 13.011727462407368
R&D to revenue (%): 2.62129169964266
SG&A to revenue (%): 68.47974674437009
Free cash flow (dilution-adjusted): 21027000
Buyback yield (%): 1.2774634463455892
Retained earnings: -113664000
Receivables turnover: 12.7125
Capitalized R&D asset: 4327000
Rosenberg metric: 0.8738907052779075
FCF margin (%): 25.214044175839987
Revenue growth (%): 2.612247911309077
Rule of 40 score: 27.826292087149064
Financial ratios for MSW — annual report dated 2025-03-31
Total revenue: 4351033.54755784
Gross profit: -167880.33419023137
Operating income: -424308.35475578404
Net income: -736600.3856041131
Capital expenditures: 1318.2519280205654
Operating cash flow: -1024318.2519280205
Depreciation & amortization: 19347.429305912596
Net tangible assets: 126475.44987146529
Owner earnings: -718571.2082262211
Return on net tangible assets (%): -568.1507430544759
Buffett classification: The Gruesome
Stock price: 3.59
Shares outstanding: 6975000
Book value: 126475.44987146533
P/B ratio: 197.9850637056278
Market cap (USD): 25040250
Debt to equity: 7.867457537203536
Current ratio: 1.0770857006395336
Quick ratio: 1.0770857006395336
Interest coverage ratio: -6.487920834889251
COGS to revenue (%): 103.85840128225303
SG&A to revenue (%): 3.2775919653401506
Free cash flow (dilution-adjusted): -1024318.2519280205
Buyback yield (%): 0
Retained earnings: -750959.2544987146
Receivables turnover: 3.5448558654617246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -84.69167798926985
FCF margin (%): -23.541952520751135
Revenue growth (%): 23.55918195212092
Rule of 40 score: 0.01722943136978472
Financial ratios for MSW — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 126475.44987146529
Buffett classification: The Gruesome
Stock price: 3.59
Shares outstanding: 6975000
Book value: 126475.44987146533
P/B ratio: 197.9850637056278
Market cap (USD): 25040250
Debt to equity: 7.867457537203536
Current ratio: 1.0770857006395336
Quick ratio: 1.0770857006395336
Buyback yield (%): 0
Retained earnings: -750959.2544987146
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOVN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 69.18681318681318
Shares outstanding: 1900714840
Market cap (USD): 131504402556.4835
Buyback yield (%): 0
Retained earnings: 78009890109.8901
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOVN.SW — annual report dated 2022-12-31
Total revenue: 47240217391.304344
Gross profit: 34651086956.521736
Operating income: 8636956521.73913
Net income: 7559782608.695652
Capital expenditures: 823913043.4782609
Operating cash flow: 15473913043.47826
Depreciation & amortization: 7288043478.260869
Net tangible assets: -1742391304.347826
Owner earnings: 14023913043.47826
Return on net tangible assets (%): -804.8658764815971
Capex to operating income (%): 9.539390888497358
Buffett classification: The Great
Stock price: 74.42391304347825
P/E ratio: 18.711997856908695
Shares outstanding: 1900714840
Book value: 64590217391.304344
P/B ratio: 2.1900938204870166
Market cap (USD): 141458635972.60867
Debt to equity: 0.4696666274001649
Current ratio: 1.2880374092685651
Quick ratio: 1.0376535455053044
Effective tax rate (%): 15.716873345408944
Interest coverage ratio: 9.932500000000001
COGS to revenue (%): 26.649179724350567
R&D to revenue (%): 21.103978279376914
SG&A to revenue (%): 28.05503785002646
Free cash flow (dilution-adjusted): 12180434782.608696
Buyback yield (%): 8.184909171474814
Retained earnings: 69065217391.30435
Inventory turnover: 1.6142160278745643
Receivables turnover: 4.3926622195269855
Capitalized R&D asset: 9969565217.391304
ROCI (R&D-adjusted, %): 14.352159016287464
FCF margin (%): 25.784036262396175
Rule of 40 score: 25.784036262396175
Financial ratios for NOVN.SW — annual report dated 2023-12-31
Total revenue: 55547619047.61905
Gross profit: 40700000000
Operating income: 11629761904.761906
Net income: 17683333333.333336
Capital expenditures: 979761904.7619048
Operating cash flow: 17211904761.904762
Depreciation & amortization: 9853571428.571428
Net tangible assets: -4229761904.7619047
Owner earnings: 26557142857.142857
Return on net tangible assets (%): -627.8637770897833
Capex to operating income (%): 8.424608455317841
Buffett classification: The Great
Stock price: 91.23809523809524
P/E ratio: 9.80683892134105
Shares outstanding: 1900714840
Book value: 55654761904.76192
P/B ratio: 3.1159526275422453
Market cap (USD): 173417601592.38095
Debt to equity: 0.5635935828877005
Current ratio: 1.1550208412277378
Quick ratio: 0.9309586964759379
Effective tax rate (%): 6.039679929847638
Interest coverage ratio: 11.425730994152048
COGS to revenue (%): 26.72953279039863
R&D to revenue (%): 24.36990998714102
SG&A to revenue (%): 26.82597513930562
Free cash flow (dilution-adjusted): 12904761904.761904
Buyback yield (%): 5.985414288660038
Retained earnings: 59105952380.952385
Inventory turnover: 2.1092508033147306
Receivables turnover: 4.976535836177474
Capitalized R&D asset: 20216513457.55694
ROCI (R&D-adjusted, %): 16.079844814670523
Rosenberg metric: 0.6067378979502838
FCF margin (%): 23.231890270038573
Revenue growth (%): 17.585443325762245
Rule of 40 score: 40.81733359580082
Financial ratios for NOVN.SW — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 108.36904761904762
Shares outstanding: 1900714840
Market cap (USD): 205978657006.1905
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOVN.SW — annual report dated 2024-12-31
Total revenue: 57468888888.888885
Gross profit: 43216666666.666664
Operating income: 16160000000
Net income: 13267777777.777777
Capital expenditures: 1422222222.222222
Operating cash flow: 19576666666.666668
Depreciation & amortization: 6743333333.333333
Net tangible assets: -8472222222.222222
Owner earnings: 18588888888.88889
Return on net tangible assets (%): -219.40983606557376
Capex to operating income (%): 8.8008800880088
Buffett classification: The Great
Stock price: 92.34444444444445
P/E ratio: 13.229077158730426
Shares outstanding: 1900714840
Book value: 49028888888.88888
P/B ratio: 3.5799394994425064
Market cap (USD): 175520455947.1111
Debt to equity: 0.7083805466165074
Current ratio: 1.0352711557228496
Quick ratio: 0.8358078907012407
Effective tax rate (%): 12.470674486803519
Interest coverage ratio: 14.457256461232605
COGS to revenue (%): 24.799891728858125
R&D to revenue (%): 19.376667568926184
SG&A to revenue (%): 24.29527087119601
Free cash flow (dilution-adjusted): 14178888888.88889
Buyback yield (%): 5.273839232423109
Retained earnings: 51734444444.44444
Inventory turnover: 2.241307006814608
Receivables turnover: 5.5909631391200945
Capitalized R&D asset: 23495238267.770878
ROCI (R&D-adjusted, %): 14.966668509202085
Rosenberg metric: 0.18591152932899463
FCF margin (%): 24.67228645450679
Revenue growth (%): 3.4587798256893754
Rule of 40 score: 28.131066280196166
Financial ratios for NOVN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 92.34444444444445
Shares outstanding: 1900714840
Market cap (USD): 175520455947.1111
Buyback yield (%): 0
Retained earnings: 51734444444.44444
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOVN.SW — quarterly report dated 2025-03-31
Total revenue: 15477272727.272728
Gross profit: 11810227272.727272
Operating income: 5298863636.363636
Net income: 4101136363.6363635
Capital expenditures: 277272727.27272725
Operating cash flow: 4142045454.5454545
Depreciation & amortization: 1311363636.3636363
Net tangible assets: -15990909090.90909
Owner earnings: 5135227272.727273
Return on net tangible assets (%): -32.11341671404207
Capex to operating income (%): 5.232682822217456
Buffett classification: The Great
Stock price: 107.89772727272728
P/E ratio: 12.501584514962595
Shares outstanding: 1900714840
Book value: 43695454545.454544
P/B ratio: 4.69345870326641
Market cap (USD): 205082811429.54547
Debt to equity: 0.8132216789763862
Current ratio: 0.7940795091558873
Quick ratio: 0.6097283279041082
Effective tax rate (%): 18.10755616065351
Interest coverage ratio: 17.27037037037037
COGS to revenue (%): 23.69309838472834
R&D to revenue (%): 17.37151248164464
SG&A to revenue (%): 22.452276064610864
Free cash flow (dilution-adjusted): 2146590909.0909092
Buyback yield (%): 1.5049353063037814
Retained earnings: 45271590909.09091
Inventory turnover: 0.5536112540744553
Receivables turnover: 1.5610315186246417
Capitalized R&D asset: 2688636363.6363635
ROCI (R&D-adjusted, %): 8.827995322166894
FCF margin (%): 13.869309838472835
Rule of 40 score: 13.869309838472835
Financial ratios for NOVN.SW — quarterly report dated 2025-06-30
Total revenue: 18545000000
Gross profit: 14392500000
Operating income: 6080000000
Net income: 5051250000
Capital expenditures: 412500000
Operating cash flow: 8330000000
Depreciation & amortization: 1570000000
Net tangible assets: -16010000000
Owner earnings: 6208750000
Return on net tangible assets (%): -38.78044971892567
Capex to operating income (%): 6.784539473684211
Buffett classification: The Great
Stock price: 116.6625
P/E ratio: 24.227795485395013
Shares outstanding: 1900714840
Book value: 52567500000
P/B ratio: 4.2182364582964755
Market cap (USD): 221742145021.5
Debt to equity: 0.7760736196319018
Current ratio: 0.8179037648987829
Quick ratio: 0.6190326038973324
Effective tax rate (%): 11.18958287353785
Interest coverage ratio: 16.830449826989618
COGS to revenue (%): 22.391480183337826
R&D to revenue (%): 18.380965219735778
SG&A to revenue (%): 23.200323537341603
Free cash flow (dilution-adjusted): 7298750000
Buyback yield (%): 1.5299301806930141
Retained earnings: 51908750000
Inventory turnover: 0.5267163469161249
Receivables turnover: 1.616826503923278
Capitalized R&D asset: 5210136363.636364
ROCI (R&D-adjusted, %): 7.762003195084456
Rosenberg metric: 0.9604395604395607
FCF margin (%): 39.356969533566996
Revenue growth (%): 19.820851688693093
Rule of 40 score: 59.17782122226009
Financial ratios for NOVN.SW — quarterly report dated 2025-09-30
Total revenue: 17947500000
Gross profit: 13523750000
Operating income: 5626250000
Net income: 4912500000
Capital expenditures: 441250000
Operating cash flow: 8213750000
Depreciation & amortization: 1705000000
Net tangible assets: -12822500000
Owner earnings: 6176250000
Return on net tangible assets (%): -48.167284070969
Capex to operating income (%): 7.842701621861808
Buffett classification: The Great
Stock price: 121.44999999999999
P/E ratio: 16.41263294631537
Shares outstanding: 1900714840
Book value: 55940000000
P/B ratio: 4.126596662817304
Market cap (USD): 230841817317.99997
Debt to equity: 0.7155434393993565
Current ratio: 0.8811875
Quick ratio: 0.68053125
Effective tax rate (%): 6.339370829361296
Interest coverage ratio: 16.01779359430605
COGS to revenue (%): 24.648279704694247
R&D to revenue (%): 20.50424850257696
SG&A to revenue (%): 23.039420532107535
Free cash flow (dilution-adjusted): 6840000000
Buyback yield (%): 1.2465245826912081
Retained earnings: 54387500000
Inventory turnover: 0.5511602554119296
Receivables turnover: 1.598174532502226
Capitalized R&D asset: 6851112500
ROCI (R&D-adjusted, %): 5.989480695958568
Rosenberg metric: -0.2548588192152549
FCF margin (%): 38.11115754283326
Revenue growth (%): -3.2218926934483685
Rule of 40 score: 34.889264849384894
Financial ratios for NOVN.SW — quarterly report dated 2025-12-31
Total revenue: 17544303797.468353
Gross profit: 12973417721.518988
Operating income: 4577215189.873418
Net income: 3049367088.607595
Capital expenditures: 769620253.164557
Operating cash flow: 2865822784.8101263
Depreciation & amortization: 1963291139.2405062
Net tangible assets: -11200000000
Owner earnings: 4243037974.6835437
Return on net tangible assets (%): -37.88426763110307
Capex to operating income (%): 16.8141592920354
Buffett classification: The Great
Stock price: 134.63291139240505
P/E ratio: 14.952377172046429
Shares outstanding: 1900714840
Book value: 58922784810.12659
P/B ratio: 4.342951092019162
Market cap (USD): 255898772635.94934
Debt to equity: 0.7599733614041118
Current ratio: 1.1166507808490358
Quick ratio: 0.8868318791700271
Effective tax rate (%): 25.295214418893725
Interest coverage ratio: 11.894736842105264
COGS to revenue (%): 26.05339105339105
R&D to revenue (%): 22.82106782106782
SG&A to revenue (%): 24.81962481962482
Free cash flow (dilution-adjusted): 1200000000
Buyback yield (%): 0.7320932813476905
Inventory turnover: 0.5760089328441538
Receivables turnover: 1.2676056338028168
Capitalized R&D asset: 7594284968.35443
ROCI (R&D-adjusted, %): 4.302377192029269
Rosenberg metric: -0.14954681480462292
FCF margin (%): 6.8398268398268405
Revenue growth (%): -2.246531285870716
Rule of 40 score: 4.593295553956125
Financial ratios for NOVN.SW — annual report dated 2025-12-31
Total revenue: 71739240506.32912
Gross profit: 54398734177.21519
Operating income: 22334177215.189873
Net income: 17701265822.78481
Capital expenditures: 1943037974.6835442
Operating cash flow: 24232911392.405064
Depreciation & amortization: 6740506329.113924
Net tangible assets: -11200000000
Owner earnings: 22498734177.21519
Return on net tangible assets (%): -200.88155515370704
Capex to operating income (%): 8.699841305826343
Buffett classification: The Great
Stock price: 134.63291139240505
P/E ratio: 14.456523911784895
Shares outstanding: 1900714840
Book value: 58922784810.12659
P/B ratio: 4.342951092019162
Market cap (USD): 255898772635.94934
Debt to equity: 0.7599733614041118
Current ratio: 1.1166507808490358
Quick ratio: 0.8868318791700271
Effective tax rate (%): 14.585371819960862
Interest coverage ratio: 15.423076923076923
COGS to revenue (%): 24.171577795814656
R&D to revenue (%): 19.762148427850512
SG&A to revenue (%): 23.375798426086032
Free cash flow (dilution-adjusted): 17908860759.49367
Buyback yield (%): 4.55678601876684
Inventory turnover: 2.1851970011166055
Receivables turnover: 5.1832815072251694
Capitalized R&D asset: 26105215983.524208
ROCI (R&D-adjusted, %): 17.847204941022863
Rosenberg metric: 1.0041768867984107
FCF margin (%): 24.963828210466882
Revenue growth (%): 24.831438180457464
Rule of 40 score: 49.79526639092435
Financial ratios for NRIM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.13
Shares outstanding: 22244766
Market cap (USD): 203094713.58
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NRIM — annual report dated 2022-12-31
Total revenue: 129192000
Net income: 30741000
Capital expenditures: 3796000
Operating cash flow: 78072000
Depreciation & amortization: 3164000
Net tangible assets: 180140000
Owner earnings: 30109000
Return on net tangible assets (%): 16.71422227156656
Buffett classification: The Gruesome
Stock price: 11.94
P/E ratio: 8.640008654240265
Shares outstanding: 22244766
Book value: 218629000
P/B ratio: 1.2148548730497783
Market cap (USD): 265602506.04
Debt to equity: 0.15674956204346174
Effective tax rate (%): 20.140801163817738
COGS to revenue (%): 0
SG&A to revenue (%): 48.743730261935724
Free cash flow (dilution-adjusted): 73534000
Buyback yield (%): 5.330145491122716
Retained earnings: 224225000
Receivables turnover: 4.078030303030303
Capitalized R&D asset: 0
FCF margin (%): 56.918385039321315
Rule of 40 score: 56.918385039321315
Financial ratios for NRIM — annual report dated 2023-12-31
Total revenue: 129631000
Net income: 25394000
Capital expenditures: 6166000
Operating cash flow: 38775000
Depreciation & amortization: 3311000
Net tangible assets: 196247000
Owner earnings: 22539000
Return on net tangible assets (%): 11.485016331459844
Buffett classification: The Gruesome
Stock price: 13.18
P/E ratio: 11.545483810348902
Shares outstanding: 22244766
Book value: 234718000
P/B ratio: 1.2490989863580977
Market cap (USD): 293186015.88
Debt to equity: 0.1409222982472584
Effective tax rate (%): 19.659579853201723
COGS to revenue (%): 0
SG&A to revenue (%): 51.830966358355646
Free cash flow (dilution-adjusted): 31672000
Buyback yield (%): 3.0847310274517583
Retained earnings: 236037000
Receivables turnover: 2.565629576851522
Capitalized R&D asset: 0
FCF margin (%): 24.432427428624326
Revenue growth (%): 0.33980432224905566
Rule of 40 score: 24.77223175087338
Financial ratios for NRIM — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 16.95
Shares outstanding: 22244766
Market cap (USD): 377048783.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NRIM — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 18.7
Shares outstanding: 22244766
Market cap (USD): 415977124.2
Buyback yield (%): 0.00024039783483843799
Capitalized R&D asset: 0
Rule of 40 score: 0